Bentham Science Logo

Clinical Cancer Drugs

Volume 6, 2 Issues, 2019
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access

Contents

Clinical Cancer Drugs, Volume 2 - Number 2


Molecular Components of Wnt/β-catenin Pathway As Therapeutic Targets For Upper Gastrointestinal Cancers

, 2(2): 72 - 79

Nikki P. Lee, Zhi Xu, Sarwat Fatima, Timothy T. Yung, Raymond W. Y. Sun and Simon Law


DOI: 10.2174/2212697X02666151028192148



Systemic Treatment of Advanced Biliary Tract Carcinoma: Emerging Roles of Targeted Therapy and Molecular Profiling

, 2(2): 80 - 86

Edward Wyluda and Nelson S. Yee


DOI: 10.2174/2212697X02666151020212855



A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer

, 2(2): 87 - 90

Hong-tao Chen, Yi-feng Liao, Mei Xiao, Lin Ma and Hong-Yu Zhang


DOI: 10.2174/2212697X02666151026215656



Immunotherapy in Gastric Carcinoma: Current Status and Future Perspectives

, 2(2): 91 - 99

Lionel Kankeu Fonkoua and Nelson S Yee


DOI: 10.2174/2212697X02666151020212602



Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies

, 2(2): 100 - 111

Benny Johnson and Daruka Mahadevan


DOI: 10.2174/2212697X02666150602215823



The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

, 2(2): 112 - 118

Koichi Momiyama, Hidenari Nagai, Yu Ogino, Takanori Mukouzu, Daigo Matsui, Michio Kogame, Teppei Matsui, Noritaka Wakui, Mie Shinohara, Yoshinori Igarashi and Yasukiyo Sumino


DOI: 10.2174/2212697X02666150602220735



Hypericin and its Derivatives Act as Radiosensitizing Agents That Can Inhibit Tumor Initiating Cell Viability

, 2(2): 119 - 127

Moshe Schaffer, Rotem Bril, Ron Batash, Benjamin Ehernberg, Guy Leshem, Shai Rahimipour and Yuval Shaked


DOI: 10.2174/2212697X02666150511203657



Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

, 2(2): 128 - 137

Ping Wang and Xueying Sun


DOI: 10.2174/2212697X02666150622154113



Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway

, 2(2): 138 - 147

Horacio Gonzalez, Carolina Lema, Robert A. Kirken, Rosa A. Maldonado, Armando Varela- Ramirez and Renato J. Aguilera


DOI: 10.2174/2212697X02666150629174704






Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
USA

Biography View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog